How Reich was paid
$9.4M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Options | Incentive | Other | Total |
|---|---|---|---|---|---|
| Samuel J. ReichChief Executive Officer | $525,000 | $8,588,160 | $315,000 | $6,462 | $9,434,622 |
| Eddie J. Sullivan, PhD.President | $485,000 | $5,367,600 | $247,500 | $14,000 | $6,114,100 |
| Alexandra Kropotova, MDEVP, Chief Medical Officer | $540,750 | $4,294,080 | $277,449 | $14,000 | $5,126,279 |
| Lucy ToEVP, Chief Financial Officer | $475,000 | $2,147,040 | $207,572 | $1,462 | $2,831,074 |
| Christoph Bausch, PhDEVP, Chief Operating Officer | $425,000 | $1,073,520 | $170,000 | $14,000 | $1,682,520 |
What changed and why
- $9.4M$9,434,622 was CEO Samuel Reich’s 2025 total compensation, versus $2,582,790 in 2024.
- $8.6M$8,588,160 of Reich’s 2025 compensation was option awards, including a 4,800,000-share October grant.
- $6.1M$6,114,100 was President Eddie Sullivan’s 2025 total compensation, including $5,367,600 in option awards.
- $5.1M$5,126,279 was Chief Medical Officer Alexandra Kropotova’s 2025 total compensation, including $4,294,080 in option awards.
- $2.8M$2,831,074 was Chief Financial Officer Lucy To’s 2025 total compensation, including $2,147,040 in option awards.
- 45%CFO Lucy To’s employment agreement provides a potential annual cash bonus of up to 45% of base salary.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.